Healionics began with a biomedical breakthrough. After years of dedicated research, Dr. Buddy Ratner and Dr.
Andrew Marshall of the University of Washington Engineered Biomaterials group (UWEB), discovered the
“sweet spot” - the precise pore size and geometry that allows biomaterial to promote the acceptance of
biomedical devices within the body.
Ten years of research funded by the National Science Foundation, the National Institute of Health and other
related grants enabled Drs. Ratner and Marshall to create what is now known as STAR® (Sphere Templated
Angiogenic Regeneration) biomaterial, a precision-engineered three-dimensional biomaterial scaffold that is
designed to heal around a medical device and promote acceptance in the body.
The transition from scientific innovation to commercially viable biomedical solution takes more than dedicated
research, however. In 2007, Healionics Corporation was formed and obtained the exclusive, perpetual and global
license for the flagship STAR biomaterial scaffold technology. STAR’s co-inventors, Dr. Ratner and Dr. Marshall,
joined Healionics as SAB Chairman and Principal Scientist, respectively.
Today, STAR biomaterial scaffolds are being evaluated for a variety of applications by research laboratories
and healthcare manufacturers around the world. If your device is designed as a long-term implant,
to discuss how STAR biomaterial may help.